BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14699650)

  • 41. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.
    Meroni PL; Moia M; Derksen RH; Tincani A; McIntyre JA; Arnout JM; Koike T; Piette JC; Khamashta MA; Shoenfeld Y
    Lupus; 2003; 12(7):504-7. PubMed ID: 12892388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early and loud].
    Schellong S
    Vasa; 2003 May; 32(2):59-60. PubMed ID: 12945096
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral contraceptives, CRP levels and cardiovascular risk.
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):5-6. PubMed ID: 15030292
    [No Abstract]   [Full Text] [Related]  

  • 44. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
    Aujesky D; Smith KJ; Roberts MS
    Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term standard-dose warfarin to prevent thrombosis.
    Depenbrock PJ
    Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
    [No Abstract]   [Full Text] [Related]  

  • 46. [Secondary prophylaxis after cerebral infarction without cardiac source of embolism. Anticoagulants are not better than ASA according to a new extensive trial (WARSS)].
    Norrving B
    Lakartidningen; 2002 May; 99(20):2298-9. PubMed ID: 12082949
    [No Abstract]   [Full Text] [Related]  

  • 47. Ictus and antiphospholipid syndrome: how much is enough?
    Rodríguez-Castellano E; Ríos-Blanco JJ; Robles-Marhuenda A; Gil-Aguado A; Soto-Abánades C; Pérez-Valero I; Royo-Orejas A; Vázquez-Rodríguez JJ
    Autoimmunity; 2008 Mar; 41(2):140-2. PubMed ID: 18324483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticoagulation in the antiphospholipid syndrome.
    Casais P; Alberto MF; Gennari LC; Grosso SH; Meschengieser SS; Lazzari MA
    Haematologica; 2004 Apr; 89(4):503-4. PubMed ID: 15075090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of antiphospholipid syndrome.
    Tuthill JI; Khamashta MA
    J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
    Rickles FR; Marder VJ
    J Thromb Haemost; 2005 May; 3(5):842-3. PubMed ID: 15869572
    [No Abstract]   [Full Text] [Related]  

  • 51. Intensity of warfarin coagulation in the antiphospholipid syndrome.
    Crowther M; Crowther MA
    Curr Rheumatol Rep; 2010 Feb; 12(1):64-9. PubMed ID: 20425536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose warfarin coupled with lower leg compression is effective prophylaxis against thromboembolic disease after hip arthroplasty.
    Bern M; Deshmukh RV; Nelson R; Bierbaum B; Sevier N; Howie N; Losina E; Katz JN
    J Arthroplasty; 2007 Aug; 22(5):644-50. PubMed ID: 17689770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
    Khamashta MA; Hunt BJ
    J Thromb Haemost; 2005 May; 3(5):844-5. PubMed ID: 15869573
    [No Abstract]   [Full Text] [Related]  

  • 56. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.
    Scully MF
    J Thromb Haemost; 2005 May; 3(5):840-1. PubMed ID: 15869571
    [No Abstract]   [Full Text] [Related]  

  • 57. Thrombosis in the antiphospholipid-antibody syndrome.
    Slivka A; Walz E
    N Engl J Med; 1995 Sep; 333(10):665-6; author reply 666-7. PubMed ID: 7637736
    [No Abstract]   [Full Text] [Related]  

  • 58. Catastrophic antiphospholipid syndrome in a 77-year-old man.
    Godfrey G; Grimwade K; Sole T
    N Z Med J; 2008 Nov; 121(1286):120-1. PubMed ID: 19098955
    [No Abstract]   [Full Text] [Related]  

  • 59. Warfarin in antiphospholipid antibody syndrome.
    Kuruvilla A
    Lancet; 2001 Oct; 358(9291):1461-2. PubMed ID: 11705531
    [No Abstract]   [Full Text] [Related]  

  • 60. Long term, low intensity warfarin helps against deep vein thrombosis.
    Gottlieb S
    BMJ; 2003 Mar; 326(7388):516. PubMed ID: 12623891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.